Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
Phase 2
Terminated
- Conditions
- Metastatic Breast CancerFatigue
- First Posted Date
- 2016-01-01
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Meriyana Bio Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT02645175
News
No news found